Register
Login:
Share:
Email Facebook Twitter

SAR Share Chat - RSS Feed

Sareum Share Chat (SAR)



Share Price: 0.60Bid: 0.55Ask: 0.65Change: 0.00 (0.00%)No Movement on Sareum
Spread: 0.10Spread as %: 18.18%Open: 0.575High: 0.60Low: 0.575Yesterday’s Close: 0.60


Share Discussion for Sareum (SAR)


Thread ViewThread View
Please Login or Register to post messages
Posts per page:


Eighteen34
Posts: 143
Off Topic
Opinion:No Opinion
Price:0.48
gige
9 May '14
Heading for .25p

Why do you say that?
 
gige
Posts: 3,961
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.48
Sar
9 May '14
seems to be heading to 0.25?
Mrsape
Posts: 23
Off Topic
Opinion:No Opinion
Price:0.48
hmmmmm
9 May '14
so the price action suggests worries about dilution.
however IMHO. the lack of newsflow is reason for optmism. I have a strong belief discussions are underway (but no evidence apart from lack of news)
50sBoy
Posts: 326
Off Topic
Opinion:No Opinion
Price:0.48
anticipation
9 May '14
I would expect a little upwards movement this afternoon in anticipation of good news.
Hopkirk
Posts: 1,141
Off Topic
Opinion:No Opinion
Price:0.48
Mrsape
9 May '14
Welcome back.

Whats your opinion on CHK1 Phase 1 costs? The same as BACIT or something more complicated?
Mrsape
Posts: 23
Off Topic
Opinion:No Opinion
Price:0.48
back
9 May '14
not posted for a year.
back time. feeling we are about to rocket.
Pfizer/ AZN uncertainty interesting. can see a bit more research money and attention coming our way (ICR/ CRT etc) pending the dust settling.

GLA
50sBoy
Posts: 326
Off Topic
Opinion:No Opinion
Price:0.48
Hopkirk
8 May '14
Thanks
Always good to read success stories like that.
Hopkirk
Posts: 1,141
Off Topic
Opinion:No Opinion
Price:0.48
PCS / 50sBoy
8 May '14
The quiet period won't last but always nice to discuss the possibilities.

50sBoy. Anything is possible with funding but if someone were to pay SARs share, they would want something in return.

And just noticed this. Not SAR specific but nice background on the oncology sector, ALL (which is one of the leukaemias Aurora FLT3 is going after), immunotherapy (not measles unfortunately) but some very nice, big numbers.

We all know its high risk, but this shows what some of the rewards could be

http://www.forbes.com/sites/matthewherper/2014/05/07/is-this-how-well-cure-cancer/
PCS1954
Posts: 968
Off Topic
Opinion:No Opinion
Price:0.48
View Thread (2)
RE: PCS1954
8 May '14
Hopkirk Evening good to see a chatty bb - my point entirely if things are looking positive then Sar should be saying we have the "cake" who wants a bite because we are adding a layer, unless TM has locked into a "rolling contract", which will be somewhat disappointing if the product is improving and the finance from outside isn't.

Anyway, as you said lots of possibilities.......and so far science has been good!!

GLA
50sBoy
Posts: 326
Off Topic
Opinion:No Opinion
Price:0.48
Good reading tonight
8 May '14
I confess i know very little as to raising funds in these situations, but i would think this was all through well through before arriving where we are today.
Hopkirk, can't remember if you corrected me on this before, but isn't it possible that a backer may pay what ever is needed on behalf of Sar, or is that not possible........my thoughts only



Share Trading BrochureRequest your Free brochures on share dealing, spread betting and CFDs

Sign up for Live Prices
Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.